Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.

ABSTRACT:

Background

Glioblastoma multiforme is the most common malignant primary brain tumor in adults and is associated with poor survival rates. Symptoms often include headaches; nausea and vomiting; and progressive memory, personality, or neurologic deficits. The treatment remains a challenge, and despite the approval of multiple new therapies in the past decade, survival has not improved.

Objective

To describe treatment patterns, survival, and healthcare costs of patients with incident glioblastoma in a large US population.

Methods

For this population-based study, adult patients (aged ≥18 years) with incident malignant brain neoplasm who had undergone brain surgery between January 1, 2006, and December 31, 2010, were identified in the Truven Health Analytics MarketScan Res

SUBMITTER: Ray S 

PROVIDER: S-EPMC4070631 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature